The short-acting insulin market is experiencing notable growth fueled by rising diabetes prevalence and advancements in insulin formulations. This market’s business growth is shaped by innovation in delivery technologies and expanding patient awareness, marking significant shifts in market dynamics throughout 2024 and 2025.Market Size and Overview The short-acting insulin market is...